Venture Capital Archives - Page 26 of 99

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

THIS WEEK'S STORIES

INBRAIN Neuroelectronics Secures €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene Brain-Computer Interfaces

May 6, 2025

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

May 7, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Jaanuu Acquired by VentureOn Management in Strategic Asset Sale

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

GeneDx Completes Acquisition of Fabric Genomics to Expand Global Genomic Medicine Capabilities

Koala Health Raises $20 Million in Series B to Expand Pet Medication Delivery Platform

Most Read

Zynex Submits FDA Application for Breakthrough Laser Pulse Oximeter

Dr. Ellen Marmur Joins MedSpa Partners, Strengthening Northeast Presence and Industry Leadership

Ted Myles Named CEO of Cellarity as Company Prepares for First Clinical Trial

XPRIZE Healthspan Awards First Round of Winners in $101M Global Competition to Advance Healthy Aging

EDITOR PICKS

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

THIS WEEK'S STORIES

INBRAIN Neuroelectronics Secures €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene Brain-Computer Interfaces

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

POPULAR CATEGORY

ABOUT US

FOLLOW US